Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
BioHarvest Sciences partners with Saffron Tech to advance high-value botanical nutraceuticals
MP3•Episode home
Manage episode 516870533 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce a significant milestone — a strategic Contract Development and Manufacturing Organization agreement with Saffron Tech, an agritech leader pioneering advanced and scalable saffron cultivation. The collaboration is focused on developing and commercializing saffron-derived botanical compounds using BioHarvest’s patented Botanical Synthesis™ platform. Under the partnership structure, Saffron Tech will own 75% of any newly developed saffron compositions and their associated IP and commercialization rights, while BioHarvest will retain a 25% stake. Sobel explained that once development is completed, BioHarvest plans to leverage its large-scale production capabilities to manufacture the compound for a new line of saffron-based nutraceutical products, sold directly through its consumer channels. These formulations will aim to harness saffron’s well-established functional benefits, including support for cognitive performance, eye health, mood balance, and antioxidant activity. Saffron Tech brings a groundbreaking production model to the partnership. It is the first company to successfully produce multiple cycles of premium-grade saffron year-round, rather than relying on traditional seasonal farming. This innovation is especially impactful given saffron’s market dynamics — it is widely known as the world’s most expensive spice, commonly priced above $10,000 per kilogram due to high labor intensity and limited global supply, with Iran accounting for more than 80% of current production. Alongside the partnership announcement, Sobel provided a business update, reporting preliminary unaudited Q3 2025 revenue guidance of approximately $9.1 million, aligned with management expectations. Unaudited adjusted EBITDA is projected between ($0.7M) and ($0.4M) for the quarter, while cash and cash equivalents as of September 30, 2025 total approximately $11 million, supporting continued operational and commercialization progress. Sobel emphasized that the collaboration with Saffron Tech marks an exciting entry into a new, high-value market segment and further demonstrates BioHarvest’s ability to apply its Botanical Synthesis™ technology to multiple natural compounds with strong consumer demand and health-driven applications. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #Vinia #SportsNutrition #Resveratrol #InformedSport #AthleteWellness #FunctionalFoods #DailySupplements #BloodFlowSupport #HydrationMarket #PlantBasedInnovation #SaffronTech #SuperSaffron #BotanicalSynthesis #Nutraceuticals
…
continue reading
608 episodes
MP3•Episode home
Manage episode 516870533 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce a significant milestone — a strategic Contract Development and Manufacturing Organization agreement with Saffron Tech, an agritech leader pioneering advanced and scalable saffron cultivation. The collaboration is focused on developing and commercializing saffron-derived botanical compounds using BioHarvest’s patented Botanical Synthesis™ platform. Under the partnership structure, Saffron Tech will own 75% of any newly developed saffron compositions and their associated IP and commercialization rights, while BioHarvest will retain a 25% stake. Sobel explained that once development is completed, BioHarvest plans to leverage its large-scale production capabilities to manufacture the compound for a new line of saffron-based nutraceutical products, sold directly through its consumer channels. These formulations will aim to harness saffron’s well-established functional benefits, including support for cognitive performance, eye health, mood balance, and antioxidant activity. Saffron Tech brings a groundbreaking production model to the partnership. It is the first company to successfully produce multiple cycles of premium-grade saffron year-round, rather than relying on traditional seasonal farming. This innovation is especially impactful given saffron’s market dynamics — it is widely known as the world’s most expensive spice, commonly priced above $10,000 per kilogram due to high labor intensity and limited global supply, with Iran accounting for more than 80% of current production. Alongside the partnership announcement, Sobel provided a business update, reporting preliminary unaudited Q3 2025 revenue guidance of approximately $9.1 million, aligned with management expectations. Unaudited adjusted EBITDA is projected between ($0.7M) and ($0.4M) for the quarter, while cash and cash equivalents as of September 30, 2025 total approximately $11 million, supporting continued operational and commercialization progress. Sobel emphasized that the collaboration with Saffron Tech marks an exciting entry into a new, high-value market segment and further demonstrates BioHarvest’s ability to apply its Botanical Synthesis™ technology to multiple natural compounds with strong consumer demand and health-driven applications. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #Vinia #SportsNutrition #Resveratrol #InformedSport #AthleteWellness #FunctionalFoods #DailySupplements #BloodFlowSupport #HydrationMarket #PlantBasedInnovation #SaffronTech #SuperSaffron #BotanicalSynthesis #Nutraceuticals
…
continue reading
608 episodes
Tất cả các tập
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.